Welcome to the ByHeart Pediatric Nutrition Coalition!

Know Your Macronutrients: Carbohydrates

  • 9 January 2025
Contributors
Christopher Peltier, MD, FAAP | ByHeart Consultant
Christopher Peltier, MD, FAAP | ByHeart Consultant
TL;DR

Mature human milk contains up to 7% (60-70 g/L) carbohydrates, mostly in the form of lactose.

TL;DR

Lactose is a source of dietary energy for infants. It is also involved in calcium absorption, increasing stool transit time, and it acts as a food source (probiotic) for friendly gut microbes.

TL;DR

Infant formulas may contain carbohydrate sources such as lactose, maltodextrin, corn syrup solids, and sucrose, among others. While all ingredients are approved by the FDA for use in infant formula, each has different functional health outcomes for infants.

TL;DR

Despite common belief, lactose intolerance is incredibly rare in infants!

TL;DR

Prebiotic fibers, which are also carbohydrates, are mostly indigestible to the infant, but they support infant gut health by supporting the gut microflora.

Introduction

Carbohydrates are a type of macronutrient (components of foods that are broken down and absorbed by the body to support the maintenance of life) that provide one of the main sources of dietary energy for infant growth and development.1 Carbohydrates are either hydrolyzed (broken down) in the small intestine to provide energy to the body, or are, in the case of dietary fiber, resistant to hydrolysis.2 In addition to being a primary energy source for the body, carbohydrates also help shape the gut microbiome and gastrointestinal tract.3 Carbohydrates are found in many foods like bread, pasta, fruit, vegetables, pastries, cookies, and dairy products. Infants also consume carbohydrates in human milk and infant formula – mature milk contains up to 7% (60-70 g/L) carbohydrates, primarily lactose,4 and formula can contain different sources of carbohydrates such as lactose, maltodextrin, or corn syrup solids. To learn more, see the ‘Fast Facts: Carbohydrates’ box for more in-depth information. 

FDA Requirements

The United States Food & Drug Administration (FDA) establishes strict standards for infant formula ingredients in terms of ingredient quantity, but infant formula companies have flexibility when it comes to ingredient type. This means that infant formula companies have choices about which carbohydrate sources to include in their formulas, including lactose, corn syrup solids, maltodextrin, sucrose, glucose, glucose syrup, maltose, pre-cooked starch, and gelatinized starch. Importantly, sucrose and/or glucose are only permitted under specific circumstances (e.g., in hydrolyzed infant formula). 

Carbohydrate sources may have different functional impacts on infant health. For example, potential impacts of corn syrup solids and maltodextrin include negative alterations of the gut microbiome,5 increased risk of obesity,6,7 and possible implications for early learned preference for sweet taste due to higher glycemic indices.6,7 Lactose, a slow-release disaccharide (a carbohydrate made up of two sugar units, glucose and galactose), is the predominant carbohydrate source in mature human milk.7 Not only is it associated with reduced stool transit time,8 but it acts as a prebiotic in the small intestine by promoting the growth of commensal bacteria.7–9 

Lactose: A Shift in Paradigm

Lactose used as a carbohydrate source was previously believed to result in maldigestion and malabsorption in infants.10–12 Advancements in human milk science, however, have established lactose as the predominant carbohydrate source in human milk, and nearly all infants are equipped with adequate lactase (the intestinal brush border enzyme that hydrolyzes lactose) to adequately digest lactose.10 Infant formulas containing lactose are therefore well-tolerated by most healthy term infants. While there are clinical classifications of lactose intolerance in infants (e.g., developmental lactase deficiency in infants <34 weeks gestation, secondary lactose intolerance, or congenital lactase deficiency), these conditions are rare11 and low-lactose and lactose-free formulas for healthy, term infants are very rarely clinically indicated. Lactose is also known to lessen reward potential (i.e., the motivation to consume additional, or excessive, palatable foods) with its low glycemic index of 46, and to be less cariogenic than glucose.7 Lactose is also utilized in synthesis of oligosaccharides, glycoproteins, and glycolipids,8 and to enhance absorption of calcium, sodium, and water.13 

Nutrient Spotlight: Prebiotic Fibers

Prebiotics are mostly indigestible carbohydrates that undergo fermentation by commensal bacteria. Human milk oligosaccharides (HMO), fructo-oligosaccharides (FOS), and galacto-oligosaccharides (GOS) are three types of prebiotics that help establish the infant gut microbiome. They are very important during an infant’s first 1,000 days, as this time represents a critical window for gut microbiome development associated with maturation of the infant’s immune system.14 

There are several hundred types of HMOs naturally found in human milk, and although they provide no direct energy to the infant, they are known to have structure-specific biological functions. HMOs have several key functions, including, but not limited to, selectively feeding the commensal probiotic Bifidobacteria in the infant gastrointestinal tract and influencing immune system development.15 Some of the smaller, more abundant HMOs have been manufactured at scale and added to some infant formulas to promote infant gut and immune health.16 However, structurally more complex HMOs are largely unavailable for commercial use.17 

While neither GOS, nor FOS, are naturally found in human milk, they are known to mimic several functions of HMOs including the promotion of the probiotics Bifidobacteria and Lactobacilli, playing a role in gut barrier function, inhibition of pathogen adhesion, and promoting softer stools.17–20 These well-researched oligosaccharides are synthesized from lactose and plants, respectively. GOS and FOS are common prebiotic ingredients in infant formulas, used to achieve gut health outcomes that are similar to those in infants fed human milk.

Christopher Peltier, MD, FAAP | ByHeart Consultant

Dr. Chris Peltier, MD, FAAP, received his BS in Biology at the University of Cincinnati and his MD at the University of Cincinnati College of Medicine.  He completed his pediatric residency and Chief Residency at Riley Hospital for Children in Indianapolis.  

Since 1999 Dr. Peltier has been a general pediatrician in independent practice at Pediatric Associates of Mount Carmel, Inc., located in Cincinnati, Ohio, and a partner in the practice since 2001.  In addition to providing routine well and ill care to his patients, his clinical interests include infant nutrition and mental health.  Dr. Peltier is an Associate Professor of Pediatrics at the University of Cincinnati College of Medicine and serves as the Director of the Community Section in the Division of General and Community Pediatrics at Cincinnati Children’s Hospital Medical Center.  His main academic interests are community-based medical education, faculty development of clinical preceptors, and professional identity formation and sense of belonging in trainees. He has precepted medical students and residents in his office for 25 years. He has presented numerous faculty development workshops locally, regionally, and nationally.  Locally he serves as the Vice President of Medical Affairs and the Chair of the Board of Directors for Tri-State Child Health Services, a physician-led network made up of primary care physicians, specialists, and Cincinnati Children’s Hospital Medical Center committed to improving the health of the children in Southwest Ohio, Eastern Indiana, and Northern Kentucky, and he is on the Board of Directors of the Cincinnati Pediatric Society.  At the state level Dr. Peltier is the Immediate Past President of the Ohio Chapter, American Academy Pediatrics where he has led numerous education, advocacy, and quality improvement projects.  During his tenure as President, the Ohio Chapter won the AAP Outstanding Very Large Chapter Award.  Nationally, Dr. Peltier recently served as the Education Chair for the AAP Council on Community Pediatrics and is a member of the AAP Practical Pediatrics Course Planning Committee.

Dr. Peltier also serves on the Pampers North American Advisory Board and is the Chief Medical Consultant, Baby Care/Pampers North America for Procter and Gamble.  He also is a ByHeart consultant and serves on ByHeart’s Medical Advisory Board. 

Dr. Peltier has received both the University of Cincinnati College of Medicine Outstanding Alumni Award, and the UC College of Medicine Distinguished Alumni Award. Dr. Peltier has received numerous teaching awards and is a member of Alpha Omega Alpha Honor Medical Society and has been elected to the American Pediatric Society, whose members are pediatricians recognized as having distinguished themselves as leaders, teachers, scholars, policymakers, and clinicians in child health, with contributions recognized nationally or internationally.

Relevance For Your Clinical Practice

In order to give evidence-based infant formula advice and recommendations to families in your practice, it is important to understand the potential health implications of different nutrients found in commercially available products. Here are health outcomes associated with some of the ingredients discussed: 

Appropriate for nearly all healthy, term infants, as they are equipped with adequate lactase during their first year of life to properly digest lactose.10 Lactose intolerance may start to appear in toddlerhood or early childhood as lactase levels start to decrease in some children.21

In addition to helping to proliferate healthy gut bacteria (prebiotics are the “food” for probiotics, after all) softer stool consistency is often seen when infants consume a formula with a prebiotic compared to one without.17-20 Human milk-fed infants will often have the softest stools compared to any formula-fed infants.22  

These carbohydrate sources are often added to “gentle” formulas and may be well-tolerated by infants who require them; however, some research has shown these ingredients to be associated with alterations of gut microbiome,5 metabolic challenges including risk for obesity,6,7 and early learned preference for sweet taste.6,7

Bread, pasta, fruit, vegetables, pastries, cookies, dairy products 

Human milk: Lactose

Infant formula: Lactose, maltodextrin, corn syrup solids.

Disclaimer

Ingredients described here represent a subset of many other factors, including other nutrients and bioactive factors, that may impact infant health. All ingredients in commercially available infant formula are approved for use by the FDA. Beyond acknowledged health outcomes, infant formula purchasing decisions should be made holistically and with respect to financial means and accessibility, the infant’s tolerance of the product, personal values, and more.

Works Cited
  • Stephen A, Alles M, De Graaf C, et al. The role and requirements of digestible dietary carbohydrates in infants and toddlers. Eur J Clin Nutr. 2012;66(7):765. doi:10.1038/EJCN.2012.27

  • Venn BJ. Macronutrients and Human Health for the 21st Century. Nutrients. 2020;12(8):1-3. doi:10.3390/NU12082363

  • Kim SY, Yi DY. Components of human breast milk: from macronutrient to microbiome and microRNA. Clin Exp Pediatr. 2020;63(8):301. doi:10.3345/CEP.2020.00059

  • Berger PK, Plows JF, Demerath EW, Fields DA. Carbohydrate composition in breast milk and its effect on infant health. Curr Opin Clin Nutr Metab Care. 2020;23(4):277. doi:10.1097/MCO.0000000000000658

  • Jones RB, Berger PK, Plows JF, et al. Lactose-reduced infant formula with added corn syrup solids is associated with a distinct gut microbiota in Hispanic infants. Gut Microbes. 2020;12(1). doi:10.1080/19490976.2020.1813534

  • Anderson CE, Whaley SE, Goran MI. Lactose-reduced infant formula with corn syrup solids and obesity risk among participants in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC). Am J Clin Nutr. 2022;116(4):1002-1009. doi:10.1093/AJCN/NQAC173

  • Romero-Velarde E, Delgado-Franco D, García-Gutiérrez M, et al. The Importance of Lactose in the Human Diet: Outcomes of a Mexican Consensus Meeting. Nutrients. 2019;11(11). doi:10.3390/NU11112737

  • Schaafsma G. Lactose and lactose derivatives as bioactive ingredients in human nutrition. Int Dairy J. 2008;18(5):458-465. doi:10.1016/J.IDAIRYJ.2007.11.013

  • Francavilla R, Calasso M, Calace L, et al. Effect of lactose on gut microbiota and metabolome of infants with cow’s milk allergy. Pediatr Allergy Immunol. 2012;23(5):420-427. doi:10.1111/J.1399-3038.2012.01286.X

  • DI Costanzo M, Berni Canani R. Lactose Intolerance: Common Misunderstandings. Ann Nutr Metab. 2018;73 Suppl 4(Suppl 4):30-37. doi:10.1159/000493669

  • Heine RG, Alrefaee F, Bachina P, et al. Lactose intolerance and gastrointestinal cow’s milk allergy in infants and children – common misconceptions revisited. World Allergy Organ J. 2017;10(1). doi:10.1186/S40413-017-0173-0

  • Darma A, Sumitro KR, Jo J, Sitorus N. Lactose Intolerance versus Cow’s Milk Allergy in Infants: A Clinical Dilemma. Nutrients. 2024;16(3). doi:10.3390/NU16030414

  • Abrams SA, Griffin IJ, Davila PM. Calcium and zinc absorption from lactose-containing and lactose-free infant formulas. Am J Clin Nutr. 2002;76(2):442-446. doi:10.1093/AJCN/76.2.442

  • Pantazi AC, Balasa AL, Mihai CM, et al. Development of Gut Microbiota in the First 1000 Days after Birth and Potential Interventions. Nutrients. 2023;15(16). doi:10.3390/NU15163647

  • Walsh C, Lane JA, van Sinderen D, Hickey RM. Human milk oligosaccharides: Shaping the infant gut microbiota and supporting health. J Funct Foods. 2020;72:104074. doi:10.1016/J.JFF.2020.104074

  • Vandenplas Y, Berger B, Carnielli VP, et al. Human Milk Oligosaccharides: 2’-Fucosyllactose (2’-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula. Nutrients. 2018;10(9). doi:10.3390/NU10091161

  • Bode L, Jantscher-Krenn E. Structure-Function Relationships of Human Milk Oligosaccharides. Advances in Nutrition. 2012;3(3):383S. doi:10.3945/AN.111.001404

  • Ratsika A, Codagnone MC, O’mahony S, Stanton C, Cryan JF. Priming for Life: Early Life Nutrition and the Microbiota-Gut-Brain Axis. Nutrients. 2021;13(2):1-33. doi:10.3390/NU13020423

  • Ambrogi V, Bottacini F, Cao L, Kuipers B, Schoterman M, van Sinderen D. Galacto-oligosaccharides as infant prebiotics: production, application, bioactive activities and future perspectives. Crit Rev Food Sci Nutr. 2023;63(6):753-766. doi:10.1080/10408398.2021.1953437

  • De Cosmi V, Mazzocchi A, Agostoni C, Visioli F. Fructooligosaccharides: From Breast Milk Components to Potential Supplements. A Systematic Review. Advances in Nutrition. 2022;13(1):318. doi:10.1093/ADVANCES/NMAB102

  • Heyman MB, Nutrition for the C on. Lactose Intolerance in Infants, Children, and Adolescents. Pediatrics. 2006;118(3):1279-1286. doi:10.1542/PEDS.2006-1721

  • Moretti E, Rakza T, Mestdagh B, Labreuche J, Turck D. The bowel movement characteristics of exclusively breastfed and exclusively formula fed infants differ during the first three months of life. Acta Paediatr. 2019;108(5):877-881. doi:10.1111/APA.14620

Stay up-to-date on the latest infant nutrition science & research.

Gain early access to exciting education events and discover impactful ways to get involved—alongside a network of thousands of pediatric healthcare professionals.

"*" indicates required fields

US Healthcare Professionals Only

This website is intended for US-based healthcare professionals.

I confirm I am a trained US healthcare professional.
Continue browsing